International Clinical Trial: The application of 68Ga-NOTA-WL12 immunoimaging in predicting the efficacy of neoadjuvant therapy for resectable squamous cell carcinoma of the head and neck

Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118440) titled 'The application of 68Ga-NOTA-WL12 immunoimaging in predicting the efficacy of neoadjuvant therapy for resectable squamous cell carcinoma of the head and neck' on Feb. 5.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital of Sichuan University

Condition: squamous cell carcinoma of the head and neck

Recruitment Status: Recruiting

Phase: Diagnostic New Technique Clincal Study

Date of First Enrollment: 2026-02-15

Target Sample Size: Test group:20;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=308300

Disclaim...